Four-cycle ABVD more toxic for older patients with Hodgkin's lymphoma

May 2013
Hem/Onc Today;5/25/2013, Vol. 14 Issue 10, p31
The article discusses the findings of a study which revealed a significant dose reduction, delay in treatment, toxicity and treatment-associated mortality among patients aged at least 60 years with early-stage Hodgkins lymphoma who took four cycles of treatment with doxorubicin, bleomycin, vinblastine and dacarbazine.


Related Articles

  • Non-Hodgkin Lymphoma. Fox, Christopher; Mead, Adam; Sellar, Rob // Current Medical Literature: Leukemia & Lymphoma;2011, Vol. 19 Issue 4, p110 

    The article discusses the findings of several studies on non-Hodgkin lymphoma. One study examined indolent mantle cell leukemia (MCL) with isolated blood and bone marrow involvement. Another examined the risk of central nervous system relapse in diffuse large B-cell lymphoma (DLBCL) patients. A...

  • CSF-1R Expression in Tumor-Associated Macrophages Is Associated With Worse Prognosis in Classical Hodgkin Lymphoma. Young Wha Koh; Chansik Park; Dok Hyun Yoon; Cheolwon Suh; Jooryung Huh // American Journal of Clinical Pathology;Apr2014, Vol. 141 Issue 4, p573 

    Objectives: The aim of this study was to determine the prognostic relevance of colony-stimulating 1 receptor (CSF-1R) expression in both Hodgkin/Reed-Sternberg (HRS) cells and the surrounding cells (non-HRS cells) in patients with classical Hodgkin lymphoma (CHL) . Methods: Diagnostic tissues...

  • G-CSF plus PBPCT offers cost-effective alternative to ABMT.  // Formulary;Nov95, Vol. 30 Issue 11, p652 

    Suggests that the combination of peripheral blood progenitor cell (PBPC) transplantation and colony-stimulating factor (G-CSF) is a cost effective treatment for Hodgin's disease or lymphoma. Comparison with autologous bone marrow transplantation costs; Comments of Thomas Smith of Virginia...

  • Non-hodgkin's lymphoma. Patlak, Margie // FDA Consumer;Dec96, Vol. 30 Issue 10, p20 

    Reports that the Non-Hodgkin's (NHL) lymphoma is now the sixth most common cancer in the United States. Symptoms of NHL; Treatments for NHL; How doctors determine the stage of the cancer according to the number and location of tumors; What procedure is used to determine the type of NHL cancer;...

  • Discussion about treatment of early-stage Hodgkin's lymphoma needed radiation oncologist. Prosnitz, Leonard R.; Kelsey, Christopher // Hem/Onc Today;4/10/2013, Vol. 14 Issue 7, p7 

    The article discusses the highlights of a roundtable discussion about the treatment of early-stage Hodgkin's lymphoma featured on the December 25, 2013 issue of "Hematology/Oncology Today."

  • Naturopathy Complements Chemo. Bennett, Peter // Alive: Canada's Natural Health & Wellness Magazine;Apr2002, Issue 234, p46 

    Focuses on the importance of naturopathy in reducing the side effects of conventional therapy in treating Hodgkin's lymphoma. Strategies for managing health challenges; Comprehensiveness of the natural program to fight cancer; Risk of chemotherapy treatment for cancer.

  • Doxorubicin liposomal.  // Reactions Weekly;2/4/2012, Issue 1387, p17 

    The article describes the case of a 37-year-old man developed palmoplantar erythrodysaesthesia (PPE) while receiving pegylated (PLD) and non-pegylated doxorubicin (NPLD) liposomal for Hodgkin's disease.

  • Osteosarcoma in an adolescent previously treated for Hodgkin's Disease. Kourti, M.; Sidi, V.; Papakonstantinou, E. // Hippokratia;2014, Vol. 18 Issue 1, p96 

    A letter to the editor is presented which reveals the development of a secondary tumor or osteosarcoma in an adolescent after treatment for Hodgkin's disease.

  • Non-Hodgkin's lymphoma trials in elderly look beyond CHOP. McNeil, Caroline; McNeil, C // JNCI: Journal of the National Cancer Institute;02/18/98, Vol. 90 Issue 4, p266 

    Presents information on researchers' launch of a randomized trial for elderly patients with intermediate-grade non-Hodgkin's lymphoma (NHL) in December, 1997. Why this trial was launched; Indepth look at the trial; Statistical information on the increase of NHL; Comments from Joseph M. Connors,...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics